[
  {
    "table": "Design",
    "nct_id": "NCT01673867",
    "fields": {
      "Route_Admin": {
        "value": "iv",
        "evidence": "Nivolumab 3 mg/kg solution intravenously (IV) every 2 weeks | Docetaxel 75 mg/m^2 concentrate for solution for intravenous infusion every 3 weeks"
      },
      "Treat_Duration": {
        "value": "until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends",
        "evidence": "Nivolumab 3 mg/kg solution intravenously (IV) every 2 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends | Docetaxel 75 mg/m^2 concentrate for solution for intravenous infusion every 3 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends"
      },
      "Add_On_Treat": {
        "value": "",
        "evidence": ""
      },
      "Adherence_Treat": {
        "value": "",
        "evidence": ""
      },
      "Enroll_Duration_Plan": {
        "value": "",
        "evidence": ""
      },
      "FU_Duration_Plan": {
        "value": "",
        "evidence": ""
      }
    },
    "batch_index": 1,
    "batch_total": 2
  },
  {
    "table": "Design",
    "nct_id": "NCT01673867",
    "fields": {
      "Central_Lab": {
        "value": "Yes",
        "evidence": "Specimens must be received by the central lab prior to randomization."
      },
      "Run_in": {
        "value": "",
        "evidence": ""
      },
      "GCP_Compliance": {
        "value": "",
        "evidence": ""
      },
      "Data_Cutoff_Date": {
        "value": "",
        "evidence": ""
      }
    },
    "batch_index": 2,
    "batch_total": 2
  }
]
